FDA label
What is anagrelide used for?
The FDA-approved uses of anagrelide, quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “Anagrelide capsules are indicated for the treatment of patients with thrombocythemia, secondary to myeloproliferative neoplasms, to reduce the elevated platelet count and the risk of thrombosis and to ameliorate associated symptoms including thrombo-hemorrhagic events.”
Run it in Rivvi
Which 2027 plans near you dropped or restricted anagrelide?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Anagrelide, capsule
Indications and Usage, quoted from the label by Torrent Pharmaceuticals Limited (ANDA209151). Cross-references to other label sections are left out.
Anagrelide capsules are indicated for the treatment of patients with thrombocythemia, secondary to myeloproliferative neoplasms, to reduce the elevated platelet count and the risk of thrombosis and to ameliorate associated symptoms including thrombo-hemorrhagic events.
Source: DailyMed label, set id 875cc32a-219c-4b6b-802a-98a47cbc9a78, version 11, effective August 17, 2026. NDC 13668-453, one of 4 listings for this product.
Questions
What is anagrelide used for?
The FDA label says: “Anagrelide capsules are indicated for the treatment of patients with thrombocythemia, secondary to myeloproliferative neoplasms, to reduce the elevated platelet count and the risk of thrombosis and to ameliorate associated symptoms including thrombo-hemorrhagic events.”
What drug class is anagrelide?
FDA lists anagrelide in the Platelet-reducing Agent established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.